Historically, stage IV melanoma carried a dismal prognosis and surgical resection was the only potential treatment offering long-term survival or palliation of symptomatic disease. With modern systemic therapies that can provide durable disease control for many patients with metastatic disease, we are actively redefining the role of surgery in metastatic melanoma. Contemporary treatment strategies can employ surgical resection in the upfront setting followed by adjuvant therapy, or used in tailored approach following systemic therapy. The combination of surgical resection and modern therapies has been associated with good long-term survival.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.yasu.2024.04.013 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!